The platelet activating factor receptor is not required for exacerbation of bacterial pneumonia following influenza

Scandinavian Journal of Infectious Diseases

Volumn 40, Issue 1, 2008, Pages 11-17

  Mccullers, Jonathan A ^a   Iverson, Amy R ^a   Murray, Peter J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL PNEUMONIA; BACTERIUM ADHERENCE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; HETEROZYGOTE; IN VITRO STUDY; INFLAMMATION; INFLUENZA; INFLUENZA VIRUS; LOBAR PNEUMONIA; LUNG; MALE; MOUSE; NONHUMAN; PATHOGENESIS; RESPIRATORY EPITHELIUM; STREPTOCOCCUS PNEUMONIAE; SUPERINFECTION;

ANIMALS; BACTERIAL ADHESION; DISEASE MODELS, ANIMAL; FEMALE; INFLUENZA A VIRUS, H1N1 SUBTYPE; MALE; MICE; MICE, KNOCKOUT; ORTHOMYXOVIRIDAE INFECTIONS; PLATELET MEMBRANE GLYCOPROTEINS; PNEUMONIA, PNEUMOCOCCAL; RECEPTORS, G-PROTEIN-COUPLED; STREPTOCOCCUS PNEUMONIAE; SUPERINFECTION;

EID: 37749002833     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540701477568     Document Type: Article

References (35)

1. Stohr, K. (2003) Preventing and treating influenza. Br Med J, 326, pp. 1223-1224.
2. Tumpey, TM, Basler, CF, Aguilar, PV, Zeng, H., Solorzano, A. and Swayne, DE (2005) Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science, 310, pp. 77-80.
3. Yuen, KY, Chan, PK, Peiris, M., Tsang, DN, Que, TL and Shortridge, KF (1998) Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet, 351, pp. 467-471.
4. Mote, JR. (1940) Virus and rickettsial diseases, pp. 429-516. Harvard University Press, Cambridge, Massachusetts
5. McCullers, JA. (2006) Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev, 19, pp. 571-582.
6. Simonsen, L. (1999) The global impact of influenza on morbidity and mortality. Vaccine, 17, p. S3.
7. Thompson, WW, Shay, DK, Weintraub, E., Brammer, L., Cox, N. and Anderson, LJ (2003) Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA, 289, pp. 179-186.
8. Simonsen, L., Reichert, TA, Viboud, C., Blackwelder, WC, Taylor, RJ and Miller, MA. (2005) Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med, 165, pp. 265-272.
9. Harford, CG, Leidler, V. and Hara, M. (1949) Effect of the lesion due to influenza virus on the resistance of mice to inhaled pneumococci. J Exp Med, 89, pp. 53-67.
10. Plotkowski, MC, Puchelle, E., Beck, G., Jacquot, J. and Hannoun, C. (1986) Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus. Am Rev Respir Dis, 134, pp. 1040-1044.
11. Stone, WJ and Swift, GW. (1919) Influenza and influenzal pneumonia at Fort Riley, Kansas. JAMA, 72, pp. 487-493.
12. Wilson, CB and Steer, P. (1919) Bacteriological and pathological observations on influenza as seen in France during 1918. Br Med J, 1, pp. 634-635.
13. Louria, D., Blumenfeld, H., Ellis, J., Kilbourne, ED and Rogers, D. (1959) Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. J Clin Invest, 38, pp. 213-265.
14. Martin, CM, Kunin, CM, Gottlieb, LS, Barnes, MW, Liu, C. and Finland, M. (1959) Asian influenza A in Boston, 1957-1958. I. Observations in 32 influenza-associated fatal cases. AMA Arch Intern Med, 103, pp. 515-531.
15. McCullers, JA and Webster, RG. (2001) A mouse model of dual infection with influenza virus and Streptococcus pneumoniae. Options for the Control of Influenza IV, pp. 601-607. Elsevier Science B.V, Amsterdam
16. McCullers, JA and Rehg, JE. (2002) Lethal synergism between influenza virus and Streptococcus pneumoniae: Characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis, 186, pp. 341-350.
17. McCullers, JA and Bartmess, KC. (2003) Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis, 187, pp. 1000-1009.
18. Cundell, DR, Gerard, NP, Gerard, C., Idanpaan-Heikkila, I. and Tuomanen, EI. (1995) Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature, 377, pp. 435-438.
19. Radin, JN, Orihuela, CJ, Murti, G., Guglielmo, C., Murray, PJ and Tuomanen, EI. (2005) Beta-Arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae. Infect Immun, 73, pp. 7827-7835.
20. Smith, MW, Schmidt, JE, Rehg, JE, Orihuela, C. and McCullers, JA. (2007) Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia following influenza. Comp Med, 57, pp. 12-18.
21. Peltola, VT, Murti, KG and McCullers, JA. (2005) Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J Infect Dis, 192, pp. 249-257.
22. Swords, WE, Buscher, BA, Ver, SI, Preston, A., Nichols, WA and Weiser, JN (2000) Non-typeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor. Mol Microbiol, 37, pp. 13-27.
23. Soares, AC, Pinho, VS, Souza, DG, Shimizu, T., Ishii, S. and Nicoli, JR (2002) Role of the platelet-activating factor (PAF) receptor during pulmonary infection with Gram- negative bacteria. Br J Pharmacol, 137, pp. 621-628.
24. Ring, A., Weiser, JN and Tuomanen, EI. (1998) Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J Clin Invest, 102, pp. 347-360.
25. Rijneveld, AW, Weijer, S., Florquin, S., Speelman, P., Shimizu, T. and Ishii, S. (2004) Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice. J Infect Dis, 189, pp. 711-716.
26. Miller, ML, Gao, G., Pestina, T., Persons, D. and Tuomanen, E. (2007) Hypersusceptibility to invasive pneumococcal infection in experimental sickle cell disease involves platelet-activating factor receptor. J Infect Dis, 195, pp. 581-584.
27. Fillon, S., Soulis, K., Rajasekaran, S., Edict-Hamilton, H., Radin, JN and Orihuela, CJ (2006) Platelet-activating factor receptor and innate immunity: Uptake of Gram-positive bacterial cell wall into host cells and cell-specific pathophysiology. J Immunol, 177, pp. 6182-6191.
28. Orihuela, CJ, Fillon, S., Smith-Sielicki, SH, Kasmi, KC El, Gao, G. and Soulis, K. (2006) Cell wall-mediated neuronal damage in early sepsis. Infect Immun, 74, pp. 3783-3789.
29. Avadhanula, V., Rodriguez, CA, DeVincenzo, JP, Wang, Y., Webby, RJ and Ulett, GC (2006) Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. J Virol, 80, pp. 1629-1636.
30. van der Sluijs, KF, van Elden, LJ, Nijhuis, M., Schuurman, R., Florquin, S. and Shimizu, T. (2006) Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during post influenza pneumonia. Am J Physiol Lung Cell Mol Physiol, 290, pp. 194-199.
31. Orihuela, CJ, Gao, G., McGee, M., Yu, J., Francis, KP and Tuomanen, E. (2003) Organ-specific models of Streptococcus pneumoniae disease. Scand J Infect Dis, 35, pp. 647-652.
32. Branger, J., Wieland, CW, Florquin, S., Maris, NA, Pater, JM and Speelman, P. (2004) Platelet-activating factor receptor-deficient mice show an unaltered clearance of non-typeable Haemophilus influenzae from their respiratory tract. Shock, 22, pp. 543-547.
33. Yoshimura, A., Lien, E., Ingalls, RR, Tuomanen, E., Dziarski, R. and Golenbock, D. (1999) Cutting edge: Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol, 163, pp. 1-5.
34. Malley, R., Henneke, P., Morse, SC, Cieslewicz, MJ, Lipsitch, M. and Thompson, CM (2003) Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci U S A, 100, pp. 1966-1971.
35. Moreno, SE, ves-Filho, JC, Rios-Santos, F., Silva, JS, Ferreira, SH and Cunha, FQ (2006) Signaling via platelet-activating factor receptors accounts for the impairment of neutrophil migration in polymicrobial sepsis. J Immunol, 177, pp. 1264-1271.